Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF

Back

ESC Premium Access

Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF

Session: Mechanisms of Heart Failure and Implications for Clinical Translation

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor S. Kristensen (Copenhagen, DK)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Soeren Lund Kristensen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 presentation

1 follower

7 more presentations in this session

Diagnostic usefulness of passive leg raising test for detection of heart failure with preserved ejection fraction compared to cycle ergometer exercise(invasive hemodynamic study)

Speaker: Associate Professor S. Hwang (Jinju, KR)

Impact of catheter ablation on HFpEF in people with comorbid atrial fibrillation and HFpEF using invasive haemodynamic testing.

Speaker: Doctor H. Sugumar (Melbourne, AU)

Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction

Speaker: Doctor A. Sayour (Budapest, HU)

Effect of sacubitril/valsartan on cognitive function in patients with HFpEF: A prespecified analysis of PARAGON-HF

Speaker: Doctor P. Dewan (Glasgow, GB)

Sex-specific effect of obesity on exercise capacity and diastolic function

Speaker: Doctor M. Jung (Seoul, KR)

Access the full session

Mechanisms of Heart Failure and Implications for Clinical Translation

Speakers: Doctor S. Kristensen, Associate Professor S. Hwang, Doctor H. Sugumar, Doctor A. Sayour, Doctor P. Dewan...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources